Trial Profile
A Randomized, Open Label, Crossover Study to Investigate the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Oct 2016
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; HGP 1201 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 19 Oct 2016 Status changed from not yet recruiting to completed.
- 26 Sep 2014 New trial record